Literature DB >> 18212054

MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.

Irena Ivanovska1, Alexey S Ball, Robert L Diaz, Jill F Magnus, Miho Kibukawa, Janell M Schelter, Sumire V Kobayashi, Lee Lim, Julja Burchard, Aimee L Jackson, Peter S Linsley, Michele A Cleary.   

Abstract

microRNAs in the miR-106b family are overexpressed in multiple tumor types and are correlated with the expression of genes that regulate the cell cycle. Consistent with these observations, miR-106b family gain of function promotes cell cycle progression, whereas loss of function reverses this phenotype. Microarray profiling uncovers multiple targets of the family, including the cyclin-dependent kinase inhibitor p21/CDKN1A. We show that p21 is a direct target of miR-106b and that its silencing plays a key role in miR-106b-induced cell cycle phenotypes. We also show that miR-106b overrides a doxorubicin-induced DNA damage checkpoint. Thus, miR-106b family members contribute to tumor cell proliferation in part by regulating cell cycle progression and by modulating checkpoint functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212054      PMCID: PMC2268421          DOI: 10.1128/MCB.01977-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  An E2F/miR-20a autoregulatory feedback loop.

Authors:  Yannick Sylvestre; Vincent De Guire; Emmanuelle Querido; Utpal K Mukhopadhyay; Véronique Bourdeau; François Major; Gerardo Ferbeyre; Pascal Chartrand
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

2.  Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.

Authors:  Anwar Hossain; Macus T Kuo; Grady F Saunders
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

3.  MicroRNA deregulation in human thyroid papillary carcinomas.

Authors:  P Pallante; R Visone; M Ferracin; A Ferraro; M T Berlingieri; G Troncone; G Chiappetta; C G Liu; M Santoro; M Negrini; C M Croce; A Fusco
Journal:  Endocr Relat Cancer       Date:  2006-06       Impact factor: 5.678

4.  Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression.

Authors:  Peter S Linsley; Janell Schelter; Julja Burchard; Miho Kibukawa; Melissa M Martin; Steven R Bartz; Jason M Johnson; Jordan M Cummins; Christopher K Raymond; Hongyue Dai; Nelson Chau; Michele Cleary; Aimee L Jackson; Michael Carleton; Lee Lim
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

5.  Expression profiling identifies microRNA signature in pancreatic cancer.

Authors:  Eun Joo Lee; Yuriy Gusev; Jinmai Jiang; Gerard J Nuovo; Megan R Lerner; Wendy L Frankel; Daniel L Morgan; Russell G Postier; Daniel J Brackett; Thomas D Schmittgen
Journal:  Int J Cancer       Date:  2007-03-01       Impact factor: 7.396

6.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

8.  Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Authors:  Christine Mayr; Michael T Hemann; David P Bartel
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

9.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.

Authors:  Jian-Fu Chen; Elizabeth M Mandel; J Michael Thomson; Qiulian Wu; Thomas E Callis; Scott M Hammond; Frank L Conlon; Da-Zhi Wang
Journal:  Nat Genet       Date:  2005-12-25       Impact factor: 38.330

10.  miR-21-mediated tumor growth.

Authors:  M-L Si; S Zhu; H Wu; Z Lu; F Wu; Y-Y Mo
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

View more
  260 in total

1.  Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7.

Authors:  Y-K Shi; Y P Yu; G C Tseng; J-H Luo
Journal:  Cancer Gene Ther       Date:  2010-06-11       Impact factor: 5.987

Review 2.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

Review 3.  Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.

Authors:  Liqin Du; Alexander Pertsemlidis
Journal:  J Mol Cell Biol       Date:  2011-01-28       Impact factor: 6.216

Review 4.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 5.  Evolution of networks and sequences in eukaryotic cell cycle control.

Authors:  Frederick R Cross; Nicolas E Buchler; Jan M Skotheim
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

6.  Developmental regulation of microRNA expression in Schwann cells.

Authors:  Nolan G Gokey; Rajini Srinivasan; Camila Lopez-Anido; Courtney Krueger; John Svaren
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

7.  Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.

Authors:  María J Bueno; Marta Gómez de Cedrón; Usua Laresgoiti; José Fernández-Piqueras; Ana M Zubiaga; Marcos Malumbres
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

Review 8.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

9.  Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues.

Authors:  Tram K Lam; Stephanie Shao; Yingdong Zhao; Francesco Marincola; Angela Pesatori; Pier Alberto Bertazzi; Neil E Caporaso; Ena Wang; Maria Teresa Landi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

10.  miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.

Authors:  Jianxiang Zhang; Danjie Chen; Shuying Liang; Jun Wang; Can Liu; Caiping Nie; Zhengzheng Shan; Liuxing Wang; Qinxia Fan; Feng Wang
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.